XML 29 R17.htm IDEA: XBRL DOCUMENT
v3.22.0.1

Capital Transactions | 12 Months Ended
--- | ---
Dec. 31, 2021
Capital Transactions |
Capital Transactions | (10) Capital Transactions Preferred Stock The Company is authorized to issue 5,000,000 shares of preferred stock in one or more series without shareholder approval. No shares of preferred stock are presently outstanding. The Company’s Board of Directors is authorized, without any further action by the shareholders of the Company, to (i) divide the preferred stock into series; (ii) designate each such series; (iii) fix and determine dividend rights; (iv) determine the price, terms and conditions on which shares of preferred stock may be redeemed; (v) determine the amount payable to holders of preferred stock in the event of voluntary or involuntary liquidation; (vi) determine any sinking fund provisions; and (vii) establish any conversion privileges. Stock Compensation On May 7, 2019, the Company’s shareholders approved the adoption of the SkyWest, Inc. 2019 Long-Term Incentive Plan, which provides for the issuance of up to 4,500,000 shares of common stock to the Company’s directors, employees, consultants and advisors (the “2019 Incentive Plan”). The 2019 Incentive Plan provides for awards in the form of options to acquire shares of common stock, stock appreciation rights, restricted stock grants, restricted stock units and performance awards. The 2019 Incentive Plan is administered by the Compensation Committee of the Company’s Board of Directors (the “Compensation Committee”). As of December 31, 2021, the 2019 Incentive Plan had 3.8 million shares remaining available for future issuance. Stock Options The fair value of stock options awarded under the Company’s stock option plans has been estimated as of the grant date using the Black-Scholes option pricing model. The Company uses historical data to estimate option exercises and employee termination in the option pricing model. The expected term of options granted is derived from the output of the option pricing model and represents the period of time that options granted are expected to be outstanding. The expected volatilities are based on the historical volatility of the Company’s traded stock and other factors. During the years ended December 31, 2021, 2020, and 2019, the Company did not grant any options to purchase shares of common stock to its employees. Options are exercisable for a period as defined by the Compensation Committee on the date granted; however, no stock option will be exercisable before six months have elapsed from the date of grant and no stock option shall be exercisable after seven years from the date of grant. The following table summarizes the stock option activity for all of the Company’s plans for the years ended December 31, 2021, 2020, and 2019. ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | 2021 | ​ | 2020 | ​ | 2019 |
​ | ​ | ​ | ​ | ​ | ​ | ​ | Weighted | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |
​ | ​ | ​ | ​ | Weighted | ​ | Average | ​ | ​ | Aggregate | ​ | ​ | ​ | Weighted | ​ | ​ | ​ | Weighted |
​ | ​ | ​ | ​ | Average | ​ | Remaining | ​ | ​ | Intrinsic | ​ | ​ | ​ | Average | ​ | ​ | ​ | Average |
​ | ​ | Number of | ​ | Exercise | ​ | Contractual | ​ | ​ | Value | ​ | Number of | ​ | Exercise | ​ | Number of | ​ | Exercise |
​ | ​ | Options | ​ | Price | ​ | Term | ​ | ​ | ($000) | ​ | Options | ​ | Price | ​ | Options | ​ | Price |
Outstanding at beginning of year |  | 57,653 | ​ |  | 14.74 |  | 2.1 | years | ​ | $ | 1,474.5 |  | 60,231 |  | $ | 14.74 |  | 300,580 |  | $ | 13.70 | ​
Granted |  | — | ​ |  | — | ​ | ​ | ​ | ​ | ​ | ​ |  | — | ​ |  | — |  | — | ​ |  | — | ​
Exercised |  | (41,020) | ​ |  | 14.78 | ​ | ​ | ​ | ​ | ​ | ​ |  | (2,578) | ​ |  | 14.78 |  | (232,514) | ​ |  | 13.36 | ​
Cancelled |  | — | ​ |  | — | ​ | ​ | ​ | ​ | ​ | ​ |  | — | ​ |  | — |  | (7,835) | ​ |  | 15.86 | ​
Outstanding at end of year |  | 16,633 | ​ |  | 14.62 |  | 1.0 | year | ​ | $ | 410.4 |  | 57,653 | ​ |  | 14.74 |  | 60,231 | ​ |  | 14.74 | ​
Exercisable at December 31, 2021 |  | 16,633 | ​ | ​ | 14.62 | ​ | 1.0 | year | ​ | $ | 410.4 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Exercisable at December 31, 2020 |  | 57,653 | ​ | ​ | 14.74 | ​ | 2.1 | years | ​ | $ | 1,474.5 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ The total intrinsic value of options to acquire shares of the Company’s common stock that were exercised during the years ended December 31, 2021, 2020 and 2019 was $1.8 million, $0.1 million and $10.5 million, respectively. All of the Company’s stock options were vested as of December 31, 2021. The following table summarizes information about the Company’s stock options outstanding at December 31, 2021:
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | Options Outstanding | ​ | Options Exercisable |
​ | ​ | ​ | ​ | ​ | ​ | Weighted Average | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |
​ | ​ | ​ | ​ | Number | ​ | Remaining | ​ | Weighted Average | ​ | Number | ​ | Weighted Average |
Range of Exercise Prices | ​ | Outstanding | ​ | Contractual Life | ​ | Exercise Price | ​ | Exercisable | ​ | Exercise Price |
$13.00 | to | $13.99 |  | 2,034 |  | 0.1 | years |  | $ | 13.51 |  | 2,034 |  | $ | 13.51 | ​
$14.00 | to | $15.00 |  | 14,599 |  | 1.1 | years | ​ |  | 14.78 |  | 14,599 | ​ |  | 14.78 | ​
$13.00 | to | $15.00 |  | 16,633 |  | 1.0 | years | ​ | $ | 14.62 |  | 16,633 | ​ | $ | 14.62 | ​
​ Restricted Stock Units (“RSUs”) During the year ended December 31, 2021, the Company granted 44,770 restricted stock units to certain of the Company’s employees under the 2019 Incentive Plan. The restricted stock units granted during the year ended December 31, 2021, have a three-year cliff-vesting period, during which the recipient must remain employed with the Company or its subsidiaries. The weighted average fair value of the restricted stock units at the date of grants made during the year ended December 31, 2021, was $44.87 per share. The following table summarizes the activity of restricted stock units granted to certain Company employees for the years ended December 31, 2021, 2020, and 2019: ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ |  | ​ | Weighted-Average |
​ | ​ | ​ | ​ | ​ | Grant-Date Fair |
​ | ​ | Number of RSUs | ​ | ​ | Value |
Non-vested RSUs outstanding at December 31, 2018 |  | 575,781 | ​ | $ | 27.71 | ​
Granted |  | 104,120 | ​ |  | 48.65 | ​
Vested |  | (251,853) | ​ |  | 14.79 | ​
Cancelled |  | (143,362) | ​ |  | 30.85 | ​
Non-vested RSUs outstanding at December 31, 2019 |  | 284,686 | ​ | $ | 45.21 | ​
Granted |  | 82,505 | ​ |  | 61.45 | ​
Vested |  | (103,231) | ​ |  | 35.81 | ​
Cancelled |  | (25,983) | ​ |  | 52.31 | ​
Non-vested RSUs outstanding at December 31, 2020 |  | 237,977 | ​ | $ | 54.15 | ​
Granted |  | 44,770 | ​ |  | 44.87 | ​
Vested |  | (69,184) | ​ |  | 53.41 | ​
Cancelled |  | (13,390) | ​ |  | 52.28 | ​
Non-vested RSUs outstanding at December 31, 2021 |  | 200,173 | ​ | $ | 52.45 | ​
​ Performance Stock Units (“PSUs”) During the year ended December 31, 2021, the Compensation Committee granted performance share units, which are performance-based restricted stock units, to certain Company employees. The PSUs have a three-year vesting period, during which the recipient must remain employed with the Company. The number of performance shares awardable from the 2021 grants can range from 0% to 250% of the original amount granted depending on the Company’s performance over two one-year measurement periods against the pre-established targets. The Company’s compensation expense for performance share units is based upon the projected number of performance share units estimated to be awarded at the conclusion of the performance period. During 2021, the Compensation Committee awarded 80% of the shares related to the performance share grant in 2018 based on the Company’s performance for the three years ended December 31, 2020, measured against the pre-established targets for the same period. This resulted in the forfeiture of 11,392 PSUs in 2021 from target related to the 2018 PSU grant. The Compensation Committee will determine the achievement of performance results and corresponding vesting of performance shares for each year’s grant in 2019, 2020 and 2021 following the conclusion of the respective performance period. At the end of each performance period, the number of shares awarded can range from 0% to 250% of the original granted amount for performance share units granted in 2021 and 0% to 200% for performance share units granted in 2020 and 2019. The following table summarizes the activity of performance share units granted at target as of December 31, 2021: ​
​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ |  | ​ | Weighted-Average
​ | ​ | ​ | ​ | ​ | Grant-Date Fair
​ | ​ | Number of PSUs | ​ | ​ | Value
Non-vested PSUs outstanding at December 31, 2018 |  | 370,917 | ​ | $ | 30.84
Granted |  | 87,864 | ​ |  | 48.81
Additional PSUs awarded from the 2016 grant | ​ | 67,853 | ​ | ​ | 14.80
Vested |  | (203,582) | ​ |  | 14.80
Cancelled |  | (89,481) | ​ |  | 34.70
Non-vested PSUs outstanding at December 31, 2019 |  | 233,571 | ​ | $ | 45.44
Granted |  | 69,132 | ​ |  | 61.45
Additional PSUs awarded from the 2017 grant | ​ | 83,042 | ​ | ​ | 35.81
Vested |  | (166,084) | ​ |  | 35.81
Cancelled |  | (23,052) | ​ |  | 53.66
Non-vested PSUs outstanding at December 31, 2020 |  | 196,609 | ​ | $ | 54.17
Granted |  | 157,210 | ​ |  | 44.87
PSUs forfeited from the 2018 grant | ​ | (11,392) | ​ | ​ | 53.41
Vested |  | (45,644) | ​ |  | 53.41
Cancelled |  | (3,991) | ​ |  | 53.30
Non-vested PSUs outstanding at December 31, 2021 |  | 292,792 | ​ | $ | 49.39
​ During the years ended December 31, 2021, 2020, and 2019, the Company granted fully-vested shares of common stock to the Company’s directors in the amounts of 21,175, 14,643 and 18,576 shares, respectively, with a weighted average grant-date fair value of $44.87, $61.45, and $48.45 respectively. During the year ended December 31, 2021, 2020 and 2019, the Company recorded equity-based compensation expense of $8.7 million, $6.8 million and $10.3 million, respectively. Additionally, in 2019, the Company incurred $7.9 million of employee severance related costs associated with the sale of ExpressJet, partially offset by a forfeiture credit of $4.5 million, primarily resulting from stock-based compensation awards that terminated upon the sale of ExpressJet during 2019. As of December 31, 2021, the Company had $16.5 million of total unrecognized compensation cost related to non-vested restricted stock grants and non-vested performance stock units. Total unrecognized compensation cost will be adjusted for future changes in estimated forfeitures. The Company expects to recognize this cost over a weighted average period of 1.9 years. Taxes The Company’s treatment of stock option grants of non-qualified options, restricted stock units and performance shares results in the creation of a deferred tax asset, which is a temporary difference, until the time that the option is exercised or the restrictions lapse. Warrants During the year ended December 31, 2021, the Company issued to Treasury warrants to purchase 203,090 shares of the Company’s common stock as part of the PSP Extension Agreement and the PSP 3 Agreement. The warrants have a five-year term from the date of issuance, and 124,773 of the warrants have an exercise price of $40.41 per share and 78,317 of the warrants have an exercise price of $57.47 per share. The weighted average fair value of these warrants was estimated at $32.52 and $22.31 per share for the 124,773 and 78,317 warrants, respectively, using the Black-Scholes option pricing model. During the year ended December 31, 2020, the Company issued to Treasury warrants to purchase 370,720 shares of the Company’s common stock as part of the CARES Act payroll support. The warrants were issued with an exercise price of $28.38 per share for a five-year term from the date of issuance. The fair value of the warrants issued to Treasury was estimated as of the grant date using the Black-Scholes option pricing model. The Company estimated a weighted average fair value of the warrants issued to Treasury at $13.57 per share. Additionally, in 2020, the Company issued to Treasury warrants to purchase 211,416 shares of the Company’s common stock in conjunction with the Company’s $60 million borrowing under the CARES Act Secured Loan facility. The warrants were issued with an exercise price of $28.38 per share for a five-year term from the date of issuance. The weighted average fair value of these warrants was estimated at $15.22 per share using the Black-Scholes option pricing model.

X
- References No definition available. + Details
Name: | skyw_CapitalTransactionsDisclosureAbstract
Namespace Prefix: | skyw_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of pertinent details related to preferred stock authorized and the entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details. + References No definition available. + Details
Name: | skyw_StockholdersEquityNoteDisclosureAndDisclosureOfCompensationRelatedCostsShareBasedPaymentsExcludingTreasuryStockAndEmployeeStockPurchasePlanDisclosureTextBlock
Namespace Prefix: | skyw_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration